Matches in Wikidata for { <http://www.wikidata.org/entity/Q38603744> ?p ?o ?g. }
- Q38603744 description "2017 nî lūn-bûn" @default.
- Q38603744 description "2017年の論文" @default.
- Q38603744 description "2017年論文" @default.
- Q38603744 description "2017年論文" @default.
- Q38603744 description "2017年論文" @default.
- Q38603744 description "2017年論文" @default.
- Q38603744 description "2017年論文" @default.
- Q38603744 description "2017年论文" @default.
- Q38603744 description "2017年论文" @default.
- Q38603744 description "2017年论文" @default.
- Q38603744 description "2017年论文" @default.
- Q38603744 description "2017年论文" @default.
- Q38603744 description "2017年论文" @default.
- Q38603744 description "2017년 논문" @default.
- Q38603744 description "article científic" @default.
- Q38603744 description "article scientific" @default.
- Q38603744 description "article scientifique" @default.
- Q38603744 description "articol științific" @default.
- Q38603744 description "articolo scientifico" @default.
- Q38603744 description "artigo científico" @default.
- Q38603744 description "artigo científico" @default.
- Q38603744 description "artigo científico" @default.
- Q38603744 description "artikel ilmiah" @default.
- Q38603744 description "artikull shkencor" @default.
- Q38603744 description "artikulong pang-agham" @default.
- Q38603744 description "artykuł naukowy" @default.
- Q38603744 description "artículo científico" @default.
- Q38603744 description "artículu científicu espublizáu en 2017" @default.
- Q38603744 description "bilimsel makale" @default.
- Q38603744 description "bài báo khoa học" @default.
- Q38603744 description "naučni članak" @default.
- Q38603744 description "scienca artikolo" @default.
- Q38603744 description "scientific article published on 28 August 2017" @default.
- Q38603744 description "scientific article published on 28 August 2017" @default.
- Q38603744 description "scientific article published on 28 August 2017" @default.
- Q38603744 description "teaduslik artikkel" @default.
- Q38603744 description "tieteellinen artikkeli" @default.
- Q38603744 description "tudományos cikk" @default.
- Q38603744 description "vedecký článok" @default.
- Q38603744 description "vetenskaplig artikel" @default.
- Q38603744 description "videnskabelig artikel" @default.
- Q38603744 description "vitenskapelig artikkel" @default.
- Q38603744 description "vitskapeleg artikkel" @default.
- Q38603744 description "vědecký článek" @default.
- Q38603744 description "wetenschappelijk artikel" @default.
- Q38603744 description "wissenschaftlicher Artikel" @default.
- Q38603744 description "επιστημονικό άρθρο" @default.
- Q38603744 description "мақолаи илмӣ" @default.
- Q38603744 description "наукова стаття, опублікована в серпні 2017" @default.
- Q38603744 description "научна статия" @default.
- Q38603744 description "научная статья" @default.
- Q38603744 description "научни чланак" @default.
- Q38603744 description "научни чланак" @default.
- Q38603744 description "מאמר מדעי" @default.
- Q38603744 description "مقالة علمية نشرت في 28 أغسطس 2017" @default.
- Q38603744 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38603744 description "บทความทางวิทยาศาสตร์" @default.
- Q38603744 description "სამეცნიერო სტატია" @default.
- Q38603744 name "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.
- Q38603744 name "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.
- Q38603744 name "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.
- Q38603744 type Item @default.
- Q38603744 label "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.
- Q38603744 label "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.
- Q38603744 label "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.
- Q38603744 prefLabel "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.
- Q38603744 prefLabel "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.
- Q38603744 prefLabel "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.
- Q38603744 P1433 Q38603744-CE18843F-76E2-4012-8D14-C51753555D90 @default.
- Q38603744 P1476 Q38603744-B27D96DE-0F0A-4C63-9DDE-85C09334EF24 @default.
- Q38603744 P2093 Q38603744-7B3177A5-209C-4549-B912-C1FE32CC443C @default.
- Q38603744 P2093 Q38603744-DC37B378-79E0-4619-BD0B-607BEDC921D1 @default.
- Q38603744 P2860 Q38603744-17579FDE-9376-4BEE-BFAD-E5A9C4B68139 @default.
- Q38603744 P2860 Q38603744-1F20A0FC-F751-467A-8106-F815D531E826 @default.
- Q38603744 P2860 Q38603744-608FD5B4-7AD2-4415-B137-A55EC648FE77 @default.
- Q38603744 P2860 Q38603744-79F5A855-9A65-4856-AF31-95AAADC94F1E @default.
- Q38603744 P2860 Q38603744-7B091EE4-672B-413D-BDAA-E34A9F5ED15F @default.
- Q38603744 P2860 Q38603744-7E1E7EBD-BCBC-4D49-9BFC-8937624853C2 @default.
- Q38603744 P2860 Q38603744-7FB8A2B9-B72B-4869-BC55-99AB6FA48D13 @default.
- Q38603744 P2860 Q38603744-C454AB5E-9A0C-453E-B84E-A30DE7828694 @default.
- Q38603744 P2860 Q38603744-CF7FE615-8F33-4FD2-9862-DF092C58A732 @default.
- Q38603744 P2860 Q38603744-D6CC8DBF-7A65-4976-90DB-40FEC1A8C14C @default.
- Q38603744 P2860 Q38603744-DF183467-36A9-4D4F-989E-F68E8F9D7B4F @default.
- Q38603744 P304 Q38603744-DACDD3B0-5645-48A6-BF3D-FCF2CAC836AC @default.
- Q38603744 P31 Q38603744-F8978480-5342-45BB-BD79-20B9C5A31071 @default.
- Q38603744 P356 Q38603744-F4CD5BBD-F8A4-4E2F-A970-0EDC03D0BB9D @default.
- Q38603744 P407 Q38603744-23001E5F-056A-44B3-B417-5B2B9713F4B6 @default.
- Q38603744 P433 Q38603744-FFD0A793-F906-48AB-997E-D34DD884540A @default.
- Q38603744 P478 Q38603744-97849912-FE58-47FC-8FAC-5E0F1CF3B7BC @default.
- Q38603744 P50 Q38603744-C0E52A38-F769-46A5-9405-61C48F50D586 @default.
- Q38603744 P50 Q38603744-F911ECB0-77A2-4EF2-BF2D-CFDA2B0E782F @default.
- Q38603744 P577 Q38603744-6214081D-18E9-4198-A469-D3C08F5CA4C8 @default.
- Q38603744 P698 Q38603744-601C5504-141E-4AEF-B1C3-0931E5BAF1D8 @default.
- Q38603744 P818 Q38603744-E18D78E3-62E7-4DEC-9BEA-A6BAAAA91F5B @default.
- Q38603744 P921 Q38603744-B8FD0EFA-A6EF-48F6-86FD-CC7C55EF8FF3 @default.
- Q38603744 P932 Q38603744-B4DBABB1-4081-449D-9732-97FF4D0724EF @default.
- Q38603744 P356 SIM.7453 @default.
- Q38603744 P698 28850689 @default.
- Q38603744 P1433 Q7604438 @default.
- Q38603744 P1476 "Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements" @default.